Patients with lymphatic malformations who receive the immunostimulant OK‐432 experience excellent long‐term outcomes
Publisher: John Wiley & Sons Inc
E-ISSN: 1651-2227|104|11|1169-1173
ISSN: 0803-5253
Source: ACTA PAEDIATRICA, Vol.104, Iss.11, 2015-11, pp. : 1169-1173
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract